Delivery Order SPE2DB24D2100-SPE2DB26FBAMQ
Award Date 10/28/25
Potential Completion Date 11/19/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,216.70 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Praxbind (idarucizumab) 5G dose formulation in 50mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 3, 2025, and performance to be executed from the vendor's location in Conshohocken, Pennsylvania. Praxbind is a reversal agent for dabigatran anticoagulation and represents a specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,433.40 to AmerisourceBergen Drug Corp for the supply of Praxbind (idarucizumab) 5G dose in 2x 2.5G/50ML vials, with a firm fixed-price contract type and an ultimate completion date of October 1, 2025. This award, issued on September 10, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Praxbind (idarucizumab) 5G Dose in 2x 2.5G/50ML vials, with a contract ceiling value of $3,216.70 and an ultimate completion date of October 20, 2025. This is a firm fixed price, non-set-aside delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Praxbind (idarucizumab) injection. The $2,881.90 firm-fixed price delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,881.90, is for the delivery of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 10, 2024. This contract award is likely part of a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a medication, with a ceiling value of $3,216.70. The contract is a firm fixed-price, non-set-aside award with a performance period extending until May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $2,852 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 4562087714 PRAXBIND 5G DOSE(2X 2.5G/50ML) 50ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 7, 2023 through September 28, 2023 to supply the requested pharmaceutical products to the DLA in support of Department of Defense requirements. As the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IDARUCIZUMAB 2.5GM 2S, a medical product. The contract has a ceiling value of $3,216.70 and a period of performance ending on July 31, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $6,433.40 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IDARUCIZUMAB 2.5GM 2S, a medical product, with a performance period through June 26, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,269.81 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...